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3-(3ʹ-hydroxy-4ʹ-methoxybenzyl)-5,6,7-trimethoxy-4H-chromen-4-one (9)
A solution of PCl 5 (180 mg, 0.86 mmol) in DMF (2.5 mL) was stirred at 20 °C for 20 min. To the reaction mixture was added BF 3 -Et 2 O (0.22 mL, 1.73 mmol) and the dihydrochalcone 1-(6-hydroxy-2,3,4-trimethoxyphenyl)-3-(3ʹ-hydroxy-4ʹ-methoxyphenyl)propan-1-one (6) (200 mg, 0.55 mmol) at 20 °C, then the mixture was stirred for 4 h followed by the addition of 1N HCl (2 mL) and dilution with ethyl acetate. The organic layer was washed with water and brine, dried over MgSO 4 , and concentrated in vacuo. The residue was purified by silica gel column chromatography (ethyl acetate / n-hexane = 1 : 4) to afford the chromone (9) (128 mg, 62% 
3-(3ʹ,4ʹ-dihydroxybenzyl)-5-hydroxy-6,7-dimethoxychroman-4-one (10) i) For synthesis from compound (8),
To a CH 2 Cl 2 (3 mL) solution of the 3-(3-hydroxy-4-methoxybenzyl)-5,6,7-trimethoxychroman-4-one (8) 
5-hydroxy-3-(3ʹ-hydroxy-4ʹ-methoxybenzyl)-6,7-dimethoxychroman-4-one (11)
To a solution of 3-(3ʹ-hydroxy-4ʹ-methoxybenzyl)-5,6,7-trimethoxychroman-4-one (8) (70 mg, 0.187 mmol) in CHCl 3 (2 mL) was added TMSI (53 µL, 0.374 mmol) at 0 °C and the reaction mixture was heated at 60 °C for 1 h. The mixture was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (ethyl acetate / n-hexane = 1 : 2) to afford compound 11 (49 mg, 73% 
2ʹ-methoxy-5ʹ-((5,6,7-trimethoxy-4-oxochroman-3-yl)methyl)phenyl benzoate (13)
To a solution of 3-(3ʹ-hydroxy-4ʹ-methoxybenzyl)-5,6,7-trimethoxychroman-4-one (8) 
5ʹ-((5,6-dihydroxy-7-methoxy-4-oxochroman-3-yl)methyl)-2ʹ-methoxyphenyl benzoate (14)
To a solution of benzoate (13) (65 mg, 0.136 mmol) in CHCl 3 (1 mL) was added TMSI (77 µL, 0.54 mmol) at 0 °C and the reaction mixture was heated at 60 °C for 1 h. The mixture was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (ethyl acetate / n-hexane = 2 : 3) to afford the compound 14 (32 mg, 52% 1-(4-(benzyloxy)-6-hydroxy-2,3-dimethoxyphenyl)-3-(3ʹ-hydroxy-4ʹ-methoxyphenyl) prop-2-en-
1-one (16)
To a solution of 4ʹ-benzyloxy-6ʹ-hydroxy-2ʹ,3ʹ-dimethoxyacetophenone (15) 
3-(3ʹ-(benzyloxy)-4ʹ-methoxyphenyl)-1-(4-(benzyloxy)-6-hydroxy-2,3 dimethoxyphenyl)propan-1-one (18)
To an acetone (5 mL) solution of the dihydrochalcone 17 (250 mg, 0.72 mmol) were added benzyl bromide (270 mg, 1.6 mmol) and K 2 CO 3 (300 mg, 2.2 mmol). After refluxing for 3 h, the reaction mixture was diluted with ethyl acetate and the organic phase was washed with water and brine, dried over 
7-(benzyloxy)-3-(3ʹ-(benzyloxy)-4ʹ-methoxybenzyl)-5,6-dimethoxy-4H-chromen-4-one (19)
To a solution of the dibenzylated dihydrochalcone (18) 
Cremastranone (1)
To a solution of 7-hydroxy-3- ( 
Biological Methods

Cell proliferation assay
The proliferation of cells was monitored by an alamarBlue based fluorescence assay as described plate reader (Biotek) with excitation and emission wavelengths of 560 nm and 590 nm respectively. Data were analysed and dose response curves generated using GraphPad Prism software (v. 6.0).
EdU incorporation assay
The assay was carried out as described before. 1 HRECs (25,000) were seeded onto coverslips coated with attachment factor and grown for 24 hours before starving in serum-free EBM-2 medium. After starvation for 12 hours, the cells were incubated with 10 µM 5-ethynyl-2ʹ-deoxyuridine (EdU) in the presence of various concentrations of 1 for 8 hours. Then the cells were processed according to the manufacturer's instructions for the click-iT EdU assay kit (Life Technologies). The images were taken using an EVOS microscope (AMG) and data were analysed using ImageJ.
In vitro angiogenesis assay
Matrigel based tube formation assay was performed to monitor the tube-formation ability of HRECs in the presence of 1 as described previously. 1 Briefly, 7500 cells in 100 µL EGM-2 medium were incubated in the presence or absence of 1 in 96-well clear plates coated with 75 µL of Matrigel basement S18 membrane. After 8 hours, images were recorded using the EVOS microscope. Number of polygons was manually counted, and the tube length was measured using Angiogenesis Analyser macros 7 in ImageJ.
In vitro scratch assay
HRECs (10 5 ) were seeded in each well of a 6-well plate coated with attachment factor (Cell Systems).
The cells were incubated in EGM-2 medium until confluent (~24 hours). The cells were then starved for 12 hours in serum free EBM-2 medium. After starvation, a straight scratch was introduced in the well by a sterile, fine 10 µL micropipette tip, and the well was rinsed twice using EBM-2 medium to remove unbound cells and debris. Then cells were incubated in EGM-2 medium in the presence of the indicated concentrations of 1 at 37 °C and 5% CO 2 . After 8 hours, images were taken using the EVOS microscope and the number of migrated cells into the scratched area was counted.
